Latest news with #Fevertree
Daily Mail
2 days ago
- Business
- Daily Mail
Posh tonic maker Fever-Tree reveals what US drinkers are buying in droves
Fevertree has shrugged off trade tariff concerns after striking a deal with a major partner, as the UK group continues to grow sales in the US market. In a trading update ahead of its annual general meeting on Thursday, the company said it was trading in line with forecasts, adding that it was making 'good progress' in the US following its partnership with Molson Coors. Fevertree noted strong momentum across the US, with brand performance described as 'well ahead of the competition'. The firm's ginger beer and ginger ale are proving a hit with consumers in the US, which is now Fevertree's biggest market, a spokesperson told This is Money. Its Bloody Mary mixer and its espresso martini cocktail mixer are also making 'great gains' across the US, Fevertree said. The company said Trump's tariffs 'do not present a structural headwind' for the business, as 'over time, they will be materially mitigated by a combination of on-shored US production and the profit guarantee mechanism'. Fevertree said it would equally split the costs of the 10 per cent tariff to be imposed on British imports to the US with brewer Molson Coors. The British company, known for its premium cocktail mixers, counts the US as its largest market. Fevertree said the transition of its distribution to Molson Coors' network of distributors was 'underway'. It claimed both businesses 'remain highly aligned and excited about the significant growth opportunity ahead'. In January, Molson Coors took a stake in Fevertree, securing exclusive rights to distribute and market the firm's cocktail mixers and tonic waters in the US. The tonic and mixer maker forecast low single-digit revenue growth and an adjusted EBITDA margin of around 12 per cent for its financial year. Fevertree said its performance across Britain remained strong, seeing it retain its 'number one position' and enjoying growth in alcoholic and non-alcoholic settings. As part of its £10 million share buyback announced earlier this year, Fevertree said it had returned around £42.5million to shareholders to date. The business said on Thursday: 'The group's capital allocation framework remains unchanged.' It added: 'We intend to retain sufficient cash for investment opportunities, primarily in operational expenditure, including increased marketing spend in growth regions. 'We are also vigilant regarding M&A opportunities that would further assist with the delivery of our strategy.' Fevertree also announced that Charles Gibb, its North America chief executive, would step down and be succeeded by Judd Hausner.
Reuters
2 days ago
- Business
- Reuters
Fevertree and Molson Coors to split cost of US tariffs
June 5 (Reuters) - Tonic maker Fevertree Drinks (FEVR.L), opens new tab said on Thursday it would equally split costs of the 10% tariff to be imposed on the UK imports to the U.S. with brewer Molson Coors (TAP.N), opens new tab, as part of their recent tie-up to mitigate the short-term impact. Fevertree also said that Charles Gibb, its North America CEO, will step down and be succeeded by Judd Hausner, who brings extensive experience from the U.S. beer network. The British company, known for its premium cocktail mixers, counts the United States as its largest market, where it continues to deliver strong momentum bolstered by its partnership with the U.S. beer maker Molson Coors. In January, Molson Coors took a stake in Fevertree, securing exclusive rights to distribute and market the British company's cocktail mixers and tonic waters in the U.S. Fevertree reiterated its annual revenue growth forecast.
Yahoo
2 days ago
- Business
- Yahoo
Fevertree and Molson Coors to split cost of US tariffs
(Reuters) -Tonic maker Fevertree Drinks said on Thursday it would equally split costs of the 10% tariff to be imposed on the UK imports to the U.S. with brewer Molson Coors, as part of their recent tie-up to mitigate the short-term impact. Fevertree also said that Charles Gibb, its North America CEO, will step down and be succeeded by Judd Hausner, who brings extensive experience from the U.S. beer network. The British company, known for its premium cocktail mixers, counts the United States as its largest market, where it continues to deliver strong momentum bolstered by its partnership with the U.S. beer maker Molson Coors. In January, Molson Coors took a stake in Fevertree, securing exclusive rights to distribute and market the British company's cocktail mixers and tonic waters in the U.S. Fevertree reiterated its annual revenue growth forecast. Sign in to access your portfolio
Yahoo
12-05-2025
- Business
- Yahoo
Why Fevertree Drinks PLC (LON:FEVR) Could Be Worth Watching
Fevertree Drinks PLC (LON:FEVR), might not be a large cap stock, but it saw a significant share price rise of 26% in the past couple of months on the AIM. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, what if the stock is still a bargain? Today we will analyse the most recent data on Fevertree Drinks's outlook and valuation to see if the opportunity still exists. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Great news for investors – Fevertree Drinks is still trading at a fairly cheap price. Our valuation model shows that the intrinsic value for the stock is £12.78, but it is currently trading at UK£8.48 on the share market, meaning that there is still an opportunity to buy now. However, given that Fevertree Drinks's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility. Check out our latest analysis for Fevertree Drinks Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Fevertree Drinks' earnings over the next few years are expected to increase by 74%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. Are you a shareholder? Since FEVR is currently undervalued, it may be a great time to increase your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation. Are you a potential investor? If you've been keeping an eye on FEVR for a while, now might be the time to make a leap. Its buoyant future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy FEVR. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision. It can be quite valuable to consider what analysts expect for Fevertree Drinks from their most recent forecasts. Luckily, you can check out what analysts are forecasting by clicking here. If you are no longer interested in Fevertree Drinks, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-05-2025
- Business
- Yahoo
Molson Coors cuts sales, profit forecasts after Q1 declines
Canadian-American brewer Molson Coors has cut its sales and profit forecasts for 2025 after a challenging first quarter. The Cobra, Staropramen and Carling producer is forecasting low single-digit year-on-year decreases in net sales on a constant-currency basis and underlying (non-GAAP) income before income taxes. In February, Molson Coors had forecast its sales by that metric would rise at a low single-digit rate in 2025. It was also projecting a mid single-digit increase in underlying income before income taxes. The new forecasts came as the company reported an 11.3% fall in net sales in the first quarter to $2.3bn. It also posted a 49.3% fall in underlying income before income taxes to $131.1m. "We have adjusted our 2025 guidance for certain key financial metrics due to the impacts of the global macroeconomic environment on the beer industry and consumer trends," the company said. CEO Gavin Hattersley added: "The macroeconomic environment and its broad effects on the beer industry and consumer, as well as competitive pressures in EMEA & APAC, impacted our financial results in the first quarter. "The global macroeconomic environment is volatile. Uncertainty around the effects of geopolitical events and global trade policy, including the impacts on economic growth, consumer confidence and expectations around inflation, and currencies has pressured the beer industry and consumption trends. Given the uncertainty is ongoing, we have adjusted our 2025 full year guidance." Hattersley noted "expected headwinds" in the first quarter, including cycling the prior year's US inventory, the discontinuation of contractual brewing arrangements in the Americas and transition fees relating to its deal for a stake in 8.5% stake in UK-based tonic and mixer maker Fevertree Drinks. It acquired the stake in January for £71m ($88.3m), which Fevertree has called a 'long-term strategic partnership'. Hattersley plans to leave the US beer major by the end the year, the group said in a statement on 14 April. He has headed the Aspall cider brewer since 2019. "Molson Coors cuts sales, profit forecasts after Q1 declines" was originally created and published by Just Drinks, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
